Education

Personal Finance How To Use TipRanks TipRanks Labs Webinar Center Glossary FAQs

About Us

About TipRanks Contact Us Careers Reviews Mobile APP

Working with TipRanks

Enterprise Solutions Top Online Brokers Become an Affiliate

News Trending Portfolio

TOOLS

Top Smart Score Stocks

STOCKS

Best High Yield Dividend Stocks

Dividend Aristocrats

Dividend Stock Comparison

New

Dividend Calculator

Dividend Returns Comparison

Dividend Calendar

Top Analysts

Top Financial Bloggers

Top-Performing Corporate Insiders

Top Hedge Fund Managers

Top Research Firms

Top Individual Investors

News

Portfolio

Personal Finance Center

Mortgages

Loans

Investing & Retirement

Spending & Savings

Calculators

Compound Interest Calculator

Student Loan Calculator

401k Retirement Calculator

Education

About Us

Working with TipRanks

Enterprise Solutions

Top Online Brokers

Become an Affiliate

Elixinol Wellness Ltd (AU:EXL)

ASX:EXL

EXL

Elixinol Wellness Ltd

RESEARCH TOOLS

Top Smart Score Stocks

Stock Screener

reports

Holding AU:EXL?

Track your performance easily

Link Broker

Elixinol Wellness Ltd (EXL) Share Price & Analysis

Q: When is Elixinol Wellness Ltd’s upcoming earnings report date?

Elixinol Wellness Ltd’s upcoming earnings report date is Feb 26, 2025 which is in 95 days.

Q: How were Elixinol Wellness Ltd’s earnings last quarter?

Elixinol Wellness Ltd released its earnings results on Aug 29, 2024. The company reported -AU$0.003 earnings per share for the quarter, missing the consensus estimate of N/A by -AU$0.003.

Q: Is Elixinol Wellness Ltd overvalued?

According to Wall Street analysts Elixinol Wellness Ltd’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Q: How many shares outstanding does Elixinol Wellness Ltd have?

Elixinol Wellness Ltd has 1,560,071,200 shares outstanding.

Q: What happened to Elixinol Wellness Ltd’s price movement after its last earnings report?

Elixinol Wellness Ltd reported an EPS of -AU$0.003 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.

7 Followers

EXL Stock Chart & Stats

Advanced Chart >

Day’s RangeAU$0 - AU$0

52-Week Range<AU$0.01 - AU$0.02

Previous CloseAU$0.01

Volume167.00K

Average Volume (3M)N/A

Market Cap

AU$7.80M

Enterprise ValueAU$6.84M

Total Cash (Recent Filing)AU$2.86M

Total Debt (Recent Filing)AU$1.90M

Price to Earnings (P/E)―

Beta0.86

Next Earnings

Feb 26, 2025

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)>-0.01

Shares OutstandingN/A

10 Day Avg. Volume4,829,921

30 Day Avg. VolumeN/A

Standard Deviation0.25

R-Squared0.24

Alpha-0.08

Financial Highlights & Ratios

Price to Book (P/B)0.00

Price to Sales (P/S)0.90

Price to Cash Flow (P/CF)N/A

P/FCF Ratio0.00

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

Elixinol Wellness Ltd News

PremiumCompany Announcements

Elixinol Wellness Quotation of 100M Securities on ASX

2d ago

PremiumCompany Announcements

Elixinol Wellness Lists New Securities on ASX

2d ago

PremiumCompany Announcements

Elixinol Wellness Ltd Approves Key Strategic Resolutions

2d ago

PremiumCompany Announcements

Elixinol Wellness Completes Share Purchase Plan

24d ago

PremiumCompany Announcements

Elixinol Wellness Announces Leadership Change and Product Innovation

26d ago

PremiumCompany Announcements

Elixinol Wellness Expands with Healthy Chef Acquisition

27d ago

PremiumCompany Announcements

Elixinol Wellness Drives Growth with Share Offer and Acquisition

1M ago

PremiumCompany Announcements

Elixinol Wellness Reports Strongest Quarter in Four Years

1M ago

See More ELLXF News >

Financials

Annual

Income Statement >

Options Prices

Currently, No data available

---

Ownership Overview

2.35% Insiders

― Mutual Funds

<0.01% Other Institutional Investors

97.65% Public Companies and

Individual Investors

Detailed Ownership Overview >

EXL FAQ

What was Elixinol Wellness Ltd’s price range in the past 12 months?

Elixinol Wellness Ltd lowest share price was <AU$0.01 and its highest was AU$0.01 in the past 12 months.

What is Elixinol Wellness Ltd’s market cap?

Currently, no data Available

When is Elixinol Wellness Ltd’s upcoming earnings report date?

Elixinol Wellness Ltd’s upcoming earnings report date is Feb 26, 2025 which is in 95 days.

How were Elixinol Wellness Ltd’s earnings last quarter?

Elixinol Wellness Ltd released its earnings results on Aug 29, 2024. The company reported -AU$0.003 earnings per share for the quarter, missing the consensus estimate of N/A by -AU$0.003.

Is Elixinol Wellness Ltd overvalued?

According to Wall Street analysts Elixinol Wellness Ltd’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Elixinol Wellness Ltd pay dividends?

Elixinol Wellness Ltd does not currently pay dividends.

What is Elixinol Wellness Ltd’s EPS estimate?

Elixinol Wellness Ltd’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Elixinol Wellness Ltd have?

Elixinol Wellness Ltd has 1,560,071,200 shares outstanding.

What happened to Elixinol Wellness Ltd’s price movement after its last earnings report?

Elixinol Wellness Ltd reported an EPS of -AU$0.003 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.

Which hedge fund is a major shareholder of Elixinol Wellness Ltd?

Currently, no hedge funds are holding shares in AU:EXL

---

Elixinol Wellness Ltd Stock Smart Score

Unlock Smart Score

Blogger Sentiment

Neutral

AU:EXL Sentiment 50%
Sector Average 72%

News Sentiment

Neutral

Bullish news 50%
Bearish news 50%

Fundamentals

Return on Equity

-85.64%

Trailing 12-Months

Asset Growth

1.90%

Trailing 12-Months

Top Smart Score Stocks >

Company Description

Elixinol Wellness Ltd

Elixinol Global Ltd operates in the industrial hemp and medicinal cannabis industries. The company is involved in the manufacture and distribution of industrial hemp-based dietary supplements and skincare products. It conducts its business in countries such as Australia and the United States of America.

---

EXL Stock 12 Month Forecast

Average Price Target

―

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"0":"AU$0","1":"AU$1","-1":"-AU$1","-0.5":"-AU$0.5","0.5":"AU$0.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":null,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">―</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":null,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">―</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":null,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">―</span>\n  </div></div>","useHTML":true}}],"tickPositions":[-1,-0.5,0,0.5,1],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Apr<br/>2023","6":"Jul<br/>2023","9":"Oct<br/>2023","12":"Dec<br/>2023","25":"Dec<br/>2024"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,0.014,0.012923076923076923,0.011846153846153847,0.01076923076923077,0.009692307692307693,0.008615384615384615,0.007538461538461539,0.006461538461538462,0.005384615384615385,0.004307692307692309,0.0032307692307692315,0.0021538461538461538,0.0010769230769230777,{"y":null,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,0.014,0.012923076923076923,0.011846153846153847,0.01076923076923077,0.009692307692307693,0.008615384615384615,0.007538461538461539,0.006461538461538462,0.005384615384615385,0.004307692307692309,0.0032307692307692315,0.0021538461538461538,0.0010769230769230777,{"y":null,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,0.014,0.012923076923076923,0.011846153846153847,0.01076923076923077,0.009692307692307693,0.008615384615384615,0.007538461538461539,0.006461538461538462,0.005384615384615385,0.004307692307692309,0.0032307692307692315,0.0021538461538461538,0.0010769230769230777,{"y":null,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":0.021,"date":1672531200000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":0.027,"date":1675209600000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":0.025,"date":1677628800000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":0.024,"date":1680307200000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":0.02,"date":1682899200000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":0.016,"date":1685577600000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":0.013,"date":1688169600000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":0.012,"date":1690848000000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":0.01,"date":1693526400000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":0.01,"date":1696118400000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":0.011,"date":1698796800000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":0.012,"date":1700179200000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":0.014,"date":1701388800000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Detailed Analyst Forecast >

Similar Stocks

CVSI

CV Sciences

―

CWBHF

Charlotte's Web Holdings

―

MJNA

Medical Marijuana

―

OGI